Chongjian Wang
Papers
9
Total Citations
71
H-Index
5
About
Chongjian Wang is a urological surgeon and clinical researcher specializing in minimally invasive urology, robotic surgery, and urologic oncology. His work centers on evaluating and optimizing surgical approaches for prostate cancer and renal cell carcinoma, with a particular emphasis on robot-assisted radical prostatectomy (RARP) and its outcomes across diverse patient populations. Through rigorous systematic reviews and meta-analyses, Wang has made significant contributions to understanding how factors such as obesity, prior transurethral resection of the prostate, and nerve-sparing techniques influence perioperative, functional, and oncologic results. His most cited work, examining neurovascular bundle-sparing RARP in high-risk prostate cancer patients (20 citations), addresses a clinically contested question with meaningful implications for patient quality of life. Wang has also contributed comparative analyses pitting robotic surgery against open, laparoscopic, and ablative modalities, helping clinicians navigate an increasingly complex surgical landscape. His research into renal cancer—including the impact of perioperative blood transfusion on survival and predictors of conversion during robotic partial nephrectomy—further broadens his scholarly footprint. Collectively, his body of work, accumulating over 70 citations within just two years, positions him as an emerging and productive voice in evidence-based urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9